![[Adobe Stock]](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_750,h_375/https://www.psypost.org/wp-content/uploads/2024/02/neurons-1-750x375.jpg)
Recent research published in Human Brain Mapping has made a significant breakthrough in understanding postpartum depression and postpartum depression with anxiety. By examining brain activity patterns, molecular genetics, and neurotransmitter systems, scientists have identified distinctive biological markers that could revolutionize the diagnosis and treatment of these conditions, providing new insights into their underlying neurological causes.
Postpartum depression (PPD) is a mental health condition that affects some women after giving birth, characterized by persistent feelings of sadness, hopelessness, and a lack of interest in the new baby or in other activities that used to bring joy. Symptoms can also include changes in appetite or sleep, fatigue, and difficulties in thinking or making decisions.
Postpartum depression with anxiety (PPD-A) involves the co-occurrence of anxiety symptoms with postpartum depression, making the condition more complex and often more severe. Women with PPD-A may experience excessive worry, feelings of impending doom, physical symptoms such as an increased heart rate, and intense fears about the baby’s health or irrational fears about their ability to care for the child.
Postpartum depression affects roughly 12% of new mothers without prior depression history, with up to 70% of those suffering also experiencing anxiety. Unlike PPD alone, PPD-A is often more severe and harder to treat. Traditionally, diagnosis has relied on subjective psychological evaluations, which can be imprecise. This has driven the need for objective, neurological markers that could lead to exact diagnosis and tailored treatments.
Previous research has shown that brain entropy, a measure of randomness or complexity in brain activity, can indicate various cognitive and mental health states. This led researchers to investigate whether brain entropy could serve as a marker for PPD and PPD-A. Additionally, genetic studies have hinted at the genetic underpinnings of these conditions but lacked detailed correlation with brain function.
“Mental health is an increasing concern worldwide, encompassing conditions such as depression, anxiety, and psychosis. However, postpartum depression, which differs from general depression due to hormonal changes, receives comparatively less attention. We aimed to explore how postpartum depression impacts brain health by examining changes in brain function,” said study author Jiaojian Wang, a full professor at the Kunming University of Science and Technology.
For their study, the researchers recruited 138 women from a maternity clinic in Chengdu, China. The participants included 62 healthy postnatal women, 45 women diagnosed with PPD, and 31 with PPD-A. Diagnoses were based on the criteria from widely recognized psychiatric manuals.
They used functional magnetic resonance imaging (fMRI) to map brain activity in a resting state and analyzed this data using a technique called sample entropy to measure brain complexity. Further, they examined how these brain activity patterns related to genetic expression profiles using data from the Allen Human Brain Atlas.
The researchers found that women with PPD-A exhibited higher levels of brain entropy, particularly in the posterior cingulate cortex and medial prefrontal cortex, regions pivotal in the default mode network (DMN), a part of the brain associated with self-referential thoughts and emotional processing. This increased entropy suggests a higher complexity and irregularity in brain activity, which correlates with the severe symptoms and cognitive disruptions observed in PPD-A. Conversely, in women with PPD, these regions did not show the same level of entropy, indicating different neurological states between those with PPD and those with PPD-A.
Furthermore, the study identified specific patterns of functional connectivity that differed among the groups. In PPD-A, there were significant alterations in how certain areas of the brain communicated with each other, suggesting disrupted brain network integration that could relate to both depressive and anxiety symptoms. These connectivity patterns provide potential targets for therapeutic interventions specifically tailored to address the unique aspects of PPD-A.
On the genetic front, the research linked these observed changes in brain function to specific genetic expressions and neurotransmitter activities. The genes most affected were those involved in synaptic signaling and neurotransmitter systems—essential components of neuronal communication and brain function. This connection underscores the possibility that long-standing changes in synaptic function and neurotransmitter balance might underlie the persistent symptoms of PPD and PPD-A.
Additionally, the neurotransmitter analysis revealed that variations in the density of neurotransmitter receptors and transporters, including those for serotonin, dopamine, and glutamate, were associated with differences in brain entropy and connectivity patterns observed between the groups. This suggests a biochemical foundation to the brain imaging findings.
“For researchers, we demonstrated that postpartum depression changes brain functions and these changes are associated with gene expression profiles and neurotransmitters,” Wang told PsyPost. “For the general public, people should be aware of the importance of postpartum depression to the physical and mental health of mothers and offspring, and should pay attention to this mental problem.”
But the study, like all research, includes limitations. For instance, the study’s cross-sectional nature makes it difficult to establish causality or track changes over time. Future research could focus on longitudinal studies from before conception through the postnatal period to better understand how these conditions develop over time. Additionally, expanding the sample size and including more diverse populations could enhance the generalizability of the findings.
“We hope to develop noninvasive and low side-effect neuromodulation therapies, such as transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS) with real-time enhanced treatment system to improve treatment efficacy,” Wang said.
The study, “Molecular basis underlying default mode network functional abnormalities in postpartum depression with and without anxiety,” was authored by Kexuan Chen, Jia Yang, Fang Li, Jin Chen, Meiling Chen, Heng Shao, Chongjun He, Defang Cai, Xing Zhang, Libo Wang, Yuejia Luo, Bochao Cheng, and Jiaojian Wang.
